Warning against increasing cases of cutaneous leishmaniasis and unavailability of meglumine in Pakistan

Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012;7(5):e35671. https://doi.org/10.1371/journal.pone.0035671

Ihsanullah M, Yousuf MJ, Ahmad N, Masood Z, Majeed S, Hassan HU, et al. Prevalence of cutaneous leishmaniasis in the largest populated city Karachi, Pakistan. Braz J Biol 2021;83:e247583. https://doi.org/10.1590/1519-6984.247583

Primary and Secondary Healthcare Department, Government of Punjab, Pakistan. Communicable Disease Control (CDC) Program and Epidemics Prevention and Control Program in Punjab. Accessed on: August 24, 2023. Available from URL: https://pshealthpunjab.gov.pk/Home/VerticalProgramChilds/46

Yesilova Y, Surucu HA, Ardic N, Aksoy M, Yesilova A, Oghumu S, et al. Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis. J Dermatolog Treat 2016;27(1):83-7. https://doi.org/10.3109/09546634.2015.1054778

Arif M, Kalsoom, Shah AA, Badshah M, Hasan F, Rehman AU, et al. Positivity, diagnosis and treatment follow-up of cutaneous leishmaniasis in war-affected areas of Bajaur, Pakistan. Parasitol Res 2022;121(3):991-8. https://doi.org/10.1007/s00436-022-07438-2

留言 (0)

沒有登入
gif